389 related articles for article (PubMed ID: 9001706)
1. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.
Schmidt DE; Ebert MH; Lynn JC; Whetsell WO
J Neural Transm (Vienna); 1997; 104(8-9):875-85. PubMed ID: 9451719
[TBL] [Abstract][Full Text] [Related]
3. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
Park TH; Mytilineou C
Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
[TBL] [Abstract][Full Text] [Related]
4. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
Wu RM; Chen RC; Chiueh CC
Ann N Y Acad Sci; 2000; 899():255-61. PubMed ID: 10863544
[TBL] [Abstract][Full Text] [Related]
5. Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium.
Koutsilieri E; Chen TS; Rausch WD; Riederer P
Eur J Pharmacol; 1996 Jun; 306(1-3):181-6. PubMed ID: 8813631
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
[TBL] [Abstract][Full Text] [Related]
7. L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.
Mytilineou C; Radcliffe P; Leonardi EK; Werner P; Olanow CW
J Neurochem; 1997 Jan; 68(1):33-9. PubMed ID: 8978707
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
Wu WR; Zhu ZT; Zhu XZ
Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
[TBL] [Abstract][Full Text] [Related]
9. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Mytilineou C; Cohen G
J Neurochem; 1985 Dec; 45(6):1951-3. PubMed ID: 3932598
[TBL] [Abstract][Full Text] [Related]
10. CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.
Waldmeier PC; Spooren WP; Hengerer B
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):526-37. PubMed ID: 11138845
[TBL] [Abstract][Full Text] [Related]
11. Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.
Wu RM; Chiueh CC; Pert A; Murphy DL
Eur J Pharmacol; 1993 Oct; 243(3):241-7. PubMed ID: 8276076
[TBL] [Abstract][Full Text] [Related]
12. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.
Thiffault C; Lamarre-Théroux L; Quirion R; Poirier J
Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165
[TBL] [Abstract][Full Text] [Related]
13. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
14. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition.
Le W; Jankovic J; Xie W; Kong R; Appel SH
Neurosci Lett; 1997 Mar; 224(3):197-200. PubMed ID: 9131670
[TBL] [Abstract][Full Text] [Related]
15. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.
Mytilineou C; Leonardi EK; Radcliffe P; Heinonen EH; Han SK; Werner P; Cohen G; Olanow CW
J Pharmacol Exp Ther; 1998 Feb; 284(2):700-6. PubMed ID: 9454817
[TBL] [Abstract][Full Text] [Related]
16. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
Mena MA; Casarejos MJ; García de Yébenes J
J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
[TBL] [Abstract][Full Text] [Related]
17. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
[TBL] [Abstract][Full Text] [Related]
18. Relationship between NMDA receptor expression and MPP+ toxicity in cultured dopaminergic cells.
Church WH; Hewett SJ
J Neurosci Res; 2003 Sep; 73(6):811-7. PubMed ID: 12949907
[TBL] [Abstract][Full Text] [Related]
19. Deprenyl rescues dopaminergic neurons in organotypic slice cultures of neonatal rat mesencephalon from N-methyl-D-aspartate toxicity.
Shimazu S; Katsuki H; Akaike A
Eur J Pharmacol; 1999 Jul; 377(1):29-34. PubMed ID: 10448922
[TBL] [Abstract][Full Text] [Related]
20. Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.
Wu RM; Murphy DL; Chiueh CC
J Neural Transm Gen Sect; 1995; 100(1):53-61. PubMed ID: 8748663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]